The pharmacologic modulation of the hypermetabolic response to burns

Clifford T. Pereira, David Herndon

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Patients with burns less than 40% TBSA do not have catabolism unless sepsis develops. Those with burns more than 40% TBSA always experience catabolism, which causes metabolic derangements that persist for at least 1 year after the injury in most body tissues. The accomplishments of the past decade have placed us in the midst of an exciting paradigm shift from what used to be a primary concern (ie, mortality) to areas that are more likely to enhance the quality of life of burn survivors. Modulating postburn hypermetabolism for the burned patient is of overwhelming importance in both the immediate care stage and the rehabilitative stage. Postburn hypermetabolism cannot be completely reversed but may be manipulated by nonpharmacologic and pharmacologic means. Early burn wound excision and complete wound closure, prevention of sepsis, the maintenance of thermal neutrality for the patient by elevation of the ambient temperature, and graded resistance exercises during convalescence are simple, highly effective primary treatment goals. Although the initial burn injury and sepsis-related complications principally determine the extent of the metabolic response in burn victims, obligatory activity, background- and procedural-related pain, and anxiety also greatly increase metabolic rates. Judicious maximal narcotic support, appropriate sedation, and supportive psychotherapy are mandatory if their effects are to be minimized. Several anabolic and anticatabolic agents are available for use during immediate care and rehabilitation. Exogenous, continuous low-dose insulin infusion, β-blockade with propranolol, and the use of the synthetic testosterone analogue oxandrolone are the most cost-effective and least toxic therapies to date. These greatly assist therapeutic minimization of the loss of lean body mass and linear growth delay and are effective in burned patients with and without sepsis. 74 Adverse effects, cost benefits, and the ease of administration and monitoring must be examined when considering the possibility of their use.

Original languageEnglish (US)
Pages (from-to)245-261
Number of pages17
JournalAdvances in Surgery
Volume39
DOIs
StatePublished - 2005

Fingerprint

Burns
Sepsis
Wounds and Injuries
Oxandrolone
Anabolic Agents
Poisons
Narcotics
Propranolol
Psychotherapy
Cost-Benefit Analysis
Survivors
Testosterone
Therapeutics
Rehabilitation
Anxiety
Hot Temperature
Maintenance
Quality of Life
Exercise
Insulin

ASJC Scopus subject areas

  • Surgery

Cite this

The pharmacologic modulation of the hypermetabolic response to burns. / Pereira, Clifford T.; Herndon, David.

In: Advances in Surgery, Vol. 39, 2005, p. 245-261.

Research output: Contribution to journalArticle

Pereira, Clifford T. ; Herndon, David. / The pharmacologic modulation of the hypermetabolic response to burns. In: Advances in Surgery. 2005 ; Vol. 39. pp. 245-261.
@article{64b726a6be114717ac393adcb04c2e71,
title = "The pharmacologic modulation of the hypermetabolic response to burns",
abstract = "Patients with burns less than 40{\%} TBSA do not have catabolism unless sepsis develops. Those with burns more than 40{\%} TBSA always experience catabolism, which causes metabolic derangements that persist for at least 1 year after the injury in most body tissues. The accomplishments of the past decade have placed us in the midst of an exciting paradigm shift from what used to be a primary concern (ie, mortality) to areas that are more likely to enhance the quality of life of burn survivors. Modulating postburn hypermetabolism for the burned patient is of overwhelming importance in both the immediate care stage and the rehabilitative stage. Postburn hypermetabolism cannot be completely reversed but may be manipulated by nonpharmacologic and pharmacologic means. Early burn wound excision and complete wound closure, prevention of sepsis, the maintenance of thermal neutrality for the patient by elevation of the ambient temperature, and graded resistance exercises during convalescence are simple, highly effective primary treatment goals. Although the initial burn injury and sepsis-related complications principally determine the extent of the metabolic response in burn victims, obligatory activity, background- and procedural-related pain, and anxiety also greatly increase metabolic rates. Judicious maximal narcotic support, appropriate sedation, and supportive psychotherapy are mandatory if their effects are to be minimized. Several anabolic and anticatabolic agents are available for use during immediate care and rehabilitation. Exogenous, continuous low-dose insulin infusion, β-blockade with propranolol, and the use of the synthetic testosterone analogue oxandrolone are the most cost-effective and least toxic therapies to date. These greatly assist therapeutic minimization of the loss of lean body mass and linear growth delay and are effective in burned patients with and without sepsis. 74 Adverse effects, cost benefits, and the ease of administration and monitoring must be examined when considering the possibility of their use.",
author = "Pereira, {Clifford T.} and David Herndon",
year = "2005",
doi = "10.1016/j.yasu.2005.05.005",
language = "English (US)",
volume = "39",
pages = "245--261",
journal = "Advances in Surgery",
issn = "0065-3411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The pharmacologic modulation of the hypermetabolic response to burns

AU - Pereira, Clifford T.

AU - Herndon, David

PY - 2005

Y1 - 2005

N2 - Patients with burns less than 40% TBSA do not have catabolism unless sepsis develops. Those with burns more than 40% TBSA always experience catabolism, which causes metabolic derangements that persist for at least 1 year after the injury in most body tissues. The accomplishments of the past decade have placed us in the midst of an exciting paradigm shift from what used to be a primary concern (ie, mortality) to areas that are more likely to enhance the quality of life of burn survivors. Modulating postburn hypermetabolism for the burned patient is of overwhelming importance in both the immediate care stage and the rehabilitative stage. Postburn hypermetabolism cannot be completely reversed but may be manipulated by nonpharmacologic and pharmacologic means. Early burn wound excision and complete wound closure, prevention of sepsis, the maintenance of thermal neutrality for the patient by elevation of the ambient temperature, and graded resistance exercises during convalescence are simple, highly effective primary treatment goals. Although the initial burn injury and sepsis-related complications principally determine the extent of the metabolic response in burn victims, obligatory activity, background- and procedural-related pain, and anxiety also greatly increase metabolic rates. Judicious maximal narcotic support, appropriate sedation, and supportive psychotherapy are mandatory if their effects are to be minimized. Several anabolic and anticatabolic agents are available for use during immediate care and rehabilitation. Exogenous, continuous low-dose insulin infusion, β-blockade with propranolol, and the use of the synthetic testosterone analogue oxandrolone are the most cost-effective and least toxic therapies to date. These greatly assist therapeutic minimization of the loss of lean body mass and linear growth delay and are effective in burned patients with and without sepsis. 74 Adverse effects, cost benefits, and the ease of administration and monitoring must be examined when considering the possibility of their use.

AB - Patients with burns less than 40% TBSA do not have catabolism unless sepsis develops. Those with burns more than 40% TBSA always experience catabolism, which causes metabolic derangements that persist for at least 1 year after the injury in most body tissues. The accomplishments of the past decade have placed us in the midst of an exciting paradigm shift from what used to be a primary concern (ie, mortality) to areas that are more likely to enhance the quality of life of burn survivors. Modulating postburn hypermetabolism for the burned patient is of overwhelming importance in both the immediate care stage and the rehabilitative stage. Postburn hypermetabolism cannot be completely reversed but may be manipulated by nonpharmacologic and pharmacologic means. Early burn wound excision and complete wound closure, prevention of sepsis, the maintenance of thermal neutrality for the patient by elevation of the ambient temperature, and graded resistance exercises during convalescence are simple, highly effective primary treatment goals. Although the initial burn injury and sepsis-related complications principally determine the extent of the metabolic response in burn victims, obligatory activity, background- and procedural-related pain, and anxiety also greatly increase metabolic rates. Judicious maximal narcotic support, appropriate sedation, and supportive psychotherapy are mandatory if their effects are to be minimized. Several anabolic and anticatabolic agents are available for use during immediate care and rehabilitation. Exogenous, continuous low-dose insulin infusion, β-blockade with propranolol, and the use of the synthetic testosterone analogue oxandrolone are the most cost-effective and least toxic therapies to date. These greatly assist therapeutic minimization of the loss of lean body mass and linear growth delay and are effective in burned patients with and without sepsis. 74 Adverse effects, cost benefits, and the ease of administration and monitoring must be examined when considering the possibility of their use.

UR - http://www.scopus.com/inward/record.url?scp=28444479519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444479519&partnerID=8YFLogxK

U2 - 10.1016/j.yasu.2005.05.005

DO - 10.1016/j.yasu.2005.05.005

M3 - Article

C2 - 16250555

AN - SCOPUS:28444479519

VL - 39

SP - 245

EP - 261

JO - Advances in Surgery

JF - Advances in Surgery

SN - 0065-3411

ER -